Ornithine decarboxylase mRNA is stabilized in an mTORC1-dependent manner in Ras-transformed cells

Sofia Origanti1, Shannon L Nowotarski, Theresa D Carr

  • 1Department of Cellular and Molecular Physiology, Penn State College of Medicine, Hershey, PA 17033, USA.

The Biochemical Journal
|November 11, 2011
PubMed

Insights

Ras activation stabilizes ornithine decarboxylase (ODC) mRNA by 8-fold, primarily through mTORC1 pathway regulation of HuR binding. This discovery offers new strategies for targeting Ras-driven tumors by controlling ODC mRNA decay.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Ras activation significantly induces ornithine decarboxylase (ODC), a key enzyme in polyamine synthesis.
  • ODC is implicated in the development and progression of Ras-driven tumors, making it a potential therapeutic target.

Purpose of the Study:

  • To investigate the mechanisms controlling ODC mRNA translation and stability in normal versus Ras12V-transformed cells.
  • To elucidate the role of the mTORC1 pathway and HuR protein in regulating ODC mRNA stability.

Main Methods:

  • Comparison of ODC mRNA translation profiles and stability in normal and Ras12V-transformed RIE-1 cells.
  • Treatment with the mTORC1 inhibitor rapamycin and siRNA knockdown of mTOR.
  • Analysis of HuR protein association with ODC mRNA and ODC 3'UTR deletion constructs.

Main Results:

  • Ras12V transformation led to an 8-fold stabilization of ODC mRNA, with only a modest increase in translation initiation.
  • Inhibition of mTORC1 (using rapamycin or siRNA) destabilized ODC mRNA and reduced HuR binding to the ODC transcript.
  • Specific regions within the ODC 3'UTR (bases 1969-2141) were identified as critical for mRNA stabilization.

Conclusions:

  • A novel mechanism for ODC synthesis control involves the regulation of ODC mRNA decay via the mTORC1 pathway and HuR.
  • Targeting ODC mRNA stability presents a potential therapeutic strategy for preventing polyamine accumulation in Ras-driven cancers.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...